TY - JOUR
KW - addiction treatment
KW - buprenorphine
KW - Opioid use disorder (OUD)
KW - patient outcomes
KW - Medication for opioid use disorder (MOUD)
KW - Retention
KW - Empirical Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - Epidemics
KW - Long Term Care
KW - Client Characteristics
KW - opioid use disorder
KW - Drug Therapy
KW - Opiates
KW - article
KW - 3383:Drug & Alcohol Rehabilitation
AU - Laura R. Lander
AU - Wanhong Zheng
AU - Jeremy D. Hustead
AU - James J. Mahoney III
AU - James H. Berry
AU - Patrick Marshalek
AU - Erin L. Winstanley
A1 - 
AD - West Virginia University, School of Medicine, Rockefeller Neuroscience Institute, Department of Behavioral Medicine and Psychiatry, Morgantown, WV, US Llander@hsc.wvu.edu; Lander, Laura R.,930 Chestnut Ridge Road,Morgantown,US,26505,West Virginia University, School of Medicine, Rockefeller Neuroscience Institute, Department of Behavioral Medicine and Psychiatry,Llander@hsc.wvu.edu
BT - Journal of the neurological sciences
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
DO - 10.1016/j.jns.2020.116712
JF - Journal of the neurological sciences
LA - English
M1 - Journal Article
PB - Elsevier Science
PY - 2020
SN - 0022-510X, 0022-510X
SP - 6
T1 - Long-term treatment retention in West Virginia's comprehensive opioid addiction treatment (COAT) program
T2 - Journal of the neurological sciences
TI - Long-term treatment retention in West Virginia's comprehensive opioid addiction treatment (COAT) program
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1016/j.jns.2020.116712
UR - https://www.proquest.com/scholarly-journals/long-term-treatment-retention-west-virginias/docview/2502243343/se-2?accountid=28100
VL - 411
VO - 0022-510X, 0022-510X
Y1 - 2020
Y2 - Apr 15
ER -